Literature DB >> 20843815

Characterization of alternatively spliced transcript variants of CLEC2D gene.

Claire Germain1, Franck Bihl, Stefan Zahn, Gwenola Poupon, Marie-Jeanne Dumaurier, Hariniaina Henintsoa Rampanarivo, Søren Berg Padkjær, Pieter Spee, Veronique M Braud.   

Abstract

Lectin-like transcript 1 (LLT1) encoded by CLEC2D gene is a C-type lectin-like molecule interacting with human CD161 (NKR-P1A) receptor expressed by natural killer cells and subsets of T cells. Using RT-PCR and sequencing, we identified several CLEC2D alternatively spliced transcript variants generated by exon skipping. In addition to the reported transcript variants 1 (LLT1) and 2, we identified a novel splice variant 4 and transcripts coding for putative soluble proteins. CLEC2D transcripts were detected primarily in hematopoietic cell lines and were found to be co-induced by the same activation signals. Although very low amounts of putative soluble CLEC2D protein isoforms could be produced by transfectants, CLEC2D isoforms 2 and 4 were efficiently expressed. By contrast to LLT1, which was detected on the cell surface, isoform 2 and 4 remained in the endoplasmic reticulum where they formed homodimers or heterodimers with LLT1. They failed to interact with CD161, leaving LLT1 as the sole ligand for this receptor. CLEC2D therefore uses gene splicing to generate protein isoforms that are structurally distinct and that have different biological activities.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843815      PMCID: PMC2975243          DOI: 10.1074/jbc.M110.179622

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.

Authors:  P Li; D L Morris; B E Willcox; A Steinle; T Spies; R K Strong
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  Cloning of a new lectin-like receptor expressed on human NK cells.

Authors:  K S Boles; R Barten; P R Kumaresan; J Trowsdale; P A Mathew
Journal:  Immunogenetics       Date:  1999-10       Impact factor: 2.846

Review 3.  The C-type lectin superfamily in the immune system.

Authors:  W I Weis; M E Taylor; K Drickamer
Journal:  Immunol Rev       Date:  1998-06       Impact factor: 12.988

4.  An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation.

Authors:  S P Atamas; J Choi; V V Yurovsky; B White
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

5.  Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.

Authors:  Helmut R Salih; Hans-Georg Rammensee; Alexander Steinle
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors.

Authors:  Koho Iizuka; Olga V Naidenko; Beatrice F M Plougastel; Daved H Fremont; Wayne M Yokoyama
Journal:  Nat Immunol       Date:  2003-07-13       Impact factor: 25.606

7.  Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

Authors:  James R Carlyle; Amanda M Jamieson; Stephan Gasser; Christopher S Clingan; Hisashi Arase; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

8.  Identification and characterization of two alternative splice variants of human interleukin-2.

Authors:  V N Tsytsikov; V V Yurovsky; S P Atamas; W J Alms; B White
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

9.  NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.

Authors:  A G Brooks; P E Posch; C J Scorzelli; F Borrego; J E Coligan
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

10.  Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells.

Authors:  M Exley; J Garcia; S P Balk; S Porcelli
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  27 in total

1.  A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.

Authors:  Julien Fassy; Kyriaki Tsalkitzi; Emie Salavagione; Nedra Hamouda-Tekaya; Véronique M Braud
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

2.  Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).

Authors:  Jun Kamishikiryo; Hideo Fukuhara; Yuki Okabe; Kimiko Kuroki; Katsumi Maenaka
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

3.  Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation.

Authors:  Catherine Do; Charles F Lang; John Lin; Huferesh Darbary; Izabela Krupska; Aulona Gaba; Lynn Petukhova; Jean-Paul Vonsattel; Mary P Gallagher; Robin S Goland; Raphael A Clynes; Andrew Dwork; John G Kral; Catherine Monk; Angela M Christiano; Benjamin Tycko
Journal:  Am J Hum Genet       Date:  2016-05-05       Impact factor: 11.025

4.  Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.

Authors:  Armando M Marrufo; Stephen O Mathew; Pankaj Chaudhary; Joseph D Malaer; Jamboor K Vishwanatha; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

5.  Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Authors:  Véronique M Braud; Jérôme Biton; Etienne Becht; Samantha Knockaert; Audrey Mansuet-Lupo; Estelle Cosson; Diane Damotte; Marco Alifano; Pierre Validire; Fabienne Anjuère; Isabelle Cremer; Nicolas Girard; Dominique Gossot; Agathe Seguin-Givelet; Marie-Caroline Dieu-Nosjean; Claire Germain
Journal:  Oncoimmunology       Date:  2018-01-29       Impact factor: 8.110

6.  Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.

Authors:  Claire Germain; Thierry Guillaudeux; Elisabeth D Galsgaard; Catherine Hervouet; Nedra Tekaya; Anne-Sophie Gallouet; Julien Fassy; Franck Bihl; Gwenola Poupon; Anne Lazzari; Pieter Spee; Fabienne Anjuère; Céline Pangault; Karin Tarte; Patrick Tas; Luc Xerri; Veronique M Braud
Journal:  Oncoimmunology       Date:  2015-04-08       Impact factor: 8.110

7.  Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.

Authors:  Claire Germain; Anders Meier; Teis Jensen; Perrine Knapnougel; Gwenola Poupon; Anne Lazzari; Anne Neisig; Katarina Håkansson; Tao Dong; Nicolai Wagtmann; Elizabeth D Galsgaard; Pieter Spee; Veronique M Braud
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

8.  The CD3ζ adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling.

Authors:  Oscar A Aguilar; Lam-Kiu Fong; Kenichi Ishiyama; William F DeGrado; Lewis L Lanier
Journal:  J Exp Med       Date:  2022-03-23       Impact factor: 14.307

9.  Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis.

Authors:  Paulina Chalan; Johan Bijzet; Minke G Huitema; Bart-Jan Kroesen; Elisabeth Brouwer; Annemieke M H Boots
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 10.  Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex.

Authors:  Yvonne Bartel; Björn Bauer; Alexander Steinle
Journal:  Front Immunol       Date:  2013-11-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.